Literature DB >> 9385431

The use of multiple antigenic peptide (MAP) in the immunodiagnosis of human immunodeficiency virus infection.

S Y Shin1, M K Lee, S Y Kim, S Y Jang, K S Hahm.   

Abstract

In order to develop an ELISA system for the antibody detection of HIV-1 or HIV-2 infections, MAPs for HIV-1 gp41(584-618) and HIV-2 gp36(574-602) corresponding to the immunodominant regions of HIV-1 gp41 and HIV-2 gp36 were used as coating antigens in the ELISA. The MAPs were synthesized by the solid phase method using Fmoc-Lys(Fmoc)-OH and their molecular weights were confirmed by tricine gel electrophoresis. The MAPs reacted with all HIV positive sera (64 samples), but did not react with HIV negative sera (48 samples) obtained from healthy blood donors. The MAPs showed high sensitivity and specificity in anti-HIV 1/2 combo panel and anti-HIV-1 seroconversion panels. The results indicated that the ELISA system using synthetic MAPs of gp41(584-618) and gp36(574-602) as coating antigens can be used as an analytical system for the immunodiagnosis of HIV-1 or HIV-2 infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9385431     DOI: 10.1080/15216549700204521

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  3 in total

1.  Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infection.

Authors:  Melissa E Dubois; Erika Hammarlund; Mark K Slifka
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

2.  Identification of three immunodominant motifs with atypical isotype profile scattered over the Onchocerca volvulus proteome.

Authors:  Ole Lagatie; Bieke Van Dorst; Lieven J Stuyver
Journal:  PLoS Negl Trop Dis       Date:  2017-01-26

3.  Switching from Multiplex to Multimodal Colorimetric Lateral Flow Immunosensor.

Authors:  Simone Cavalera; Fabio Di Nardo; Luca Forte; Francesca Marinoni; Matteo Chiarello; Claudio Baggiani; Laura Anfossi
Journal:  Sensors (Basel)       Date:  2020-11-18       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.